6 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Phase 1/2 Study of PRO-203 in Healthy Volunteers and Participants With Systemic Sclerosis.Skin and Connective Tissue Diseases, connective tissue disorder, diffuse scleroderma, scleroderma, skin disorder, systemic sclerosisRecruitingPhase 1 / Phase 22026-10-09NCT07641634
The Efficacy and Safety of Inpegsomatropin Injection in Children With Turner Syndrome (TS) and Short StatureCardiovascular Abnormalities, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Sex Chromosome Disorders, Turner syndrome, Urogenital Abnormalities, Urogenital Diseases, cardiovascular disorder, chromosomal disorder, congenital heart disease, disorder of sexual differentiation, endocrine system disorder, gonadal disorder, gonadal dysgenesis, heart disorder, hereditary disease, sex chromosome disorder of sex developmentRecruitingPhase 32026-07-22NCT07614152
A Phase III Study to Evaluate the Efficacy and Safety of MDR-001 in Adult Participants With Overweight or Obesity (MOBILE)Body Weight, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, nutritional disorder, obesity disorder, overnutritionNot yet recruitingPhase 32025-12-22NCT07274137
Real-world Study on Liver Cancer Risk in Chronic Hepatitis B Patients With Family History of Liver Cancerhepatocellular carcinomaNot yet recruitingNot stated2025-06-05NCT07007286
Study to Evaluate the Pharmacokinetic Characteristics, Safety, Tolerability, and Preliminary Efficacy of 9MW1911 in Patients With Chronic Obstructive Pulmonary Disease (COPD).Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)Active, not recruitingPhase 1 / Phase 22025-05-20NCT06175351
A Study of SCTB35 in Patients with Systemic Lupus ErythematosusSkin and Connective Tissue Diseases, autoimmune disease, connective tissue disorder, immune system disorder, systemic lupus erythematosusRecruitingPhase 1 / Phase 22025-02-21NCT06841042